Literature DB >> 6417595

Antibodies to human squamous cell carcinoma.

T E Carey, K A Kimmel, D R Schwartz, D E Richter, S R Baker, C J Krause.   

Abstract

We are studying membrane antigens of human squamous cell cancer with the use of naturally occurring autologous antibodies from patients' sera, along with a set of other serologic reagents and monoclonal antibodies raised against cultured squamous cell lines. Twenty-eight squamous cell carcinoma cell lines have been established in our laboratory from tissues obtained from 23 patients. Antibody reactivity has been found against the autologous tumor cell line in 13 of 23 patients. One of these is of sufficient titer for detailed analysis. Four cell lines are available from this patient. UM-SCC-17A is derived from the primary laryngeal carcinoma, and UM-SCC-17B is derived from a lymph node metastasis removed during the same surgical procedure. Fibroblasts have been cultured from normal mucosa, and a B-lymphoblastoid line has been developed by Epstein-Barr virus transformation of the patient's peripheral blood lymphocytes. Antibody from this patient reacts with the UM-SCC-17A and -17B tumor cell lines but does not react with the normal fibroblasts (UM-NF-17).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417595     DOI: 10.1177/019459988309100503

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  26 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.

Authors:  Mozaffarul Islam; Jharna Datta; James C Lang; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

3.  Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation.

Authors:  M J Worsham; S R Wolman; T E Carey; R J Zarbo; M S Benninger; D L Van Dyke
Journal:  Mol Pathol       Date:  1999-02

Review 4.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

5.  Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.

Authors:  D R Vlock; B Arnold; J Humpierres; D R Schwartz; S R Baker; C J Krause; N Swanson; T E Carey
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.

Authors:  A Shapira; J G Wagner; I S Wollner; J Maybaum; P L Stetson; W D Ensminger; T E Carey
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

Review 7.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Autoantibody approach for serum-based detection of head and neck cancer.

Authors:  Ho-Sheng Lin; Harvinder S Talwar; Adi L Tarca; Alexei Ionan; Madhumita Chatterjee; Bin Ye; Jerzy Wojciechowski; Saroj Mohapatra; Marc D Basson; George H Yoo; Brian Peshek; Fulvio Lonardo; Chuan-Ju G Pan; Adam J Folbe; Sorin Draghici; Judith Abrams; Michael A Tainsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

9.  RhoC expression and head and neck cancer metastasis.

Authors:  Mozaffarul Islam; Giant Lin; John C Brenner; Quintin Pan; Sofia D Merajver; Yanjun Hou; Pawan Kumar; Theodoros N Teknos
Journal:  Mol Cancer Res       Date:  2009-10-27       Impact factor: 5.852

10.  Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.

Authors:  A H Schrijvers; M Gerretsen; M van Walsum; B J Braakhuis; J J Quak; G B Snow; G A van Dongen
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.